Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Chart Review of Safety Outcomes Associated With Use of Maribavir in Patients With Post-transplant Refractory Cytomegalovirus (CMV) Infection and Comorbid Severe Chronic Kidney Disease (CKD) or Comorbid End-stage Renal Disease (ESRD), Including Patients on Peritoneal Dialysis or Hemodialysis

NCT06243731 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT06243731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06243731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Chart Review of Safety Outcomes Associated With Use of Maribavir in Patients With Post-transplant Refractory Cytomegalovirus (CMV) Infection and Comorbid Severe Chronic Kidney Disease (CKD) or Comorbid End-stage Renal Disease (ESRD), Including Patients on Peritoneal Dialysis or Hemodialysis
Lead sponsor
Takeda
Phase
Observational
Overall status
Recruiting
Start date
November 3, 2025
Completion date
January 31, 2027
Enrollment
10 (estimated)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

cytomegalovirus (cmv), kidney disease, kidney failure